|
WO2021076623A1
|
|
Systems, methods and assays for outlier clustering unsupervised learning automated report (ocular)
|
|
WO2021072125A1
|
|
Geometric paradigm for nonlinear modeling and control of neural dynamics
|
|
US2021101178A1
|
|
Electrical Tuning of Focal Size with Single-Element Planar Focused Ultrasonic Transducer
|
|
US2021094709A1
|
|
Multi-armed soft capture system
|
|
WO2021055692A1
|
|
Recovery and reuse of acid digested amine/epoxy-based composite matrices
|
|
WO2021041731A1
|
|
Assays for detecting and quantifying a biomarker of pericyte injury
|
|
US2021049465A1
|
|
Self-optimizing and self-programming computing systems: a combined compiler, complex networks, and machine learning approach
|
|
US2021035337A1
|
|
Scan-specific recurrent neural network for image reconstruction
|
|
US2021012974A1
|
|
Fully-printed all-solid-state organic flexible artificial synapse for neuromorphic computing
|
|
WO2021007236A1
|
|
Non-native o-glcnac modification of peptide hormones yields potent gpcr agonists with improved serum stability
|
|
WO2020257712A1
|
|
Granulocyte-macrophage colony-stimulating factor/elastin-like polypeptide fusion proteins and uses thereof
|
|
US2020397345A1
|
|
Human activity recognition using magnetic induction-based motion signals and deep recurrent neural networks
|
|
US2021009895A1
|
|
Luminescent janus-type, two-coordinated metal complexes
|
|
US2020390825A1
|
|
Pluripotent stem cell-directed model of autosomal dominant polycystic kidney disease for disease mechanism and drug discovery
|
|
US2020316258A1
|
|
Growth factor transduced cell-loaded ceramic scaffold for bone regeneration and repair
|
|
US2020390361A1
|
|
Method for measuring water exchange across the blood-brain barrier using mri
|
|
US2020387777A1
|
|
Lagrange coded computing: optimal design for resiliency, security, and privacy
|
|
WO2020243066A1
|
|
Long-life lithium-sulfur battery using a novel flexible bi-layer solid state electrolyte
|
|
US2020345053A1
|
|
Fasting-mimicking diet (fmd) as an intervention for alzheimer's disease (ad)
|
|
US2020337991A1
|
|
Sustained-release 9-cis retinoic acid implantable drug delivery pellets for the prevention of postsurgical edema and lymphedema
|
